Market Recap

 

 

Weekly Recap

 

A solid week for the markets as Pfizer’s vaccine distribution kicked into gear and Moderna’s was approved. And we shouldn’t forget the Chinese and Russian options. As you can see below, these are being picked up in much of the developing world.

 

On the economic front the news was downbeat in the U.S. as renewed lockdowns/restrictions had their predictable impact. The key reports:

 

Weekly Unemployment Claims

 

Another 885,000 Americans filed for first-time unemployment benefits last week, the highest level in three months.

 

 

Retail Sales

 

US retail sales declined in November by the most in seven months. Sales fell 1.1% last month from October, the second consecutive monthly decline.

 

 

Travel Stats

 

As you would expect, travel plans are being changed. Hotel occupancy fell once again this week.

 

 

At least in California people are still driving despite the more strident demands to stay home – unstoppable force meets immovable object?

 

 

Housing – A Bright Spot

 

What stands out on the positive side includes housing – Home building is booming.

 

 

Policy Leans Against the Headwinds

 

Against this backdrop both the Fed and Congress made the news.

 

Federal Reserve

 

First, the Fed met on Tuesday and Wednesday. Not much was expected and they didn’t disappoint. No change in rates and no change in their asset purchase structure. About the only thing they reiterated was the fact that they ‘really really’ promise not to tighten policy until things are back on a solid footing. This is clear by the dot plot (chart below) that shows they don’t think they will hike rates until the next election.

 

 

Chairman Powell’s comment below basically captures their view:

 

‘It’s going to take some time… We’ve been having very long expansions in the last several decades. The old model was inflation would come along and the Fed would tighten and we’d have a recession. Now inflation has been low and we haven’t had that dynamic and the result has been three of the four largest expansions in recorded history.

 

We’re thinking that this could be another long expansion. What we’re saying is we’re going to keep policy highly accommodative until the expansion is well down the tracks, and we’re not going to preemptively raise rates until we see inflation actually reaching 2%, and being on track to exceed 2%.

 

That’s a very strong commitment and we think that’s the right place to be.’

 

Congress

 

Then there is Congress. It is looking more and more likely that we’ll see another fiscal package in the next few days. Leaks and rumors abound – Greg Valliere does a good job of capturing the situation, at least as it stands now:

 

“THERE’S A REASON WHY CONGRESS has a 19% approval rating; that reason is on full display this week — an inability to move quickly when the country demands it. A pandemic aid bill will pass, but not quite yet, which means people who desperately need aid may not get it before Christmas.

 

A $900 BILLION PACKAGE OF ASSISTANCE is finally coming into focus. Fed Chairman Jerome Powell and many economists believe it isn’t enough, but it’s more generous than we anticipated earlier this week. There will be government checks of $600 or $700, plus unemployment benefits of $300 per week.

 

OTHER KEY PROVISIONS will include about $300 billion for small business, including about $257 for the Payroll Protection Program; $25 billion for rental assistance, including aid for landlords; $80 billion for schools and universities; about $16 billion for vaccine distribution, testing and tracking.

 

THE MEASURE WILL NOT INCLUDE money for state and local governments, although there’s a drive to “backdoor” aid with $90 billion to the Federal Emergency Management Agency (FEMA). There also isn’t money for liability protection to protect against lawsuits. The need to act on these two issues makes another bill — in February — increasingly likely, especially if jobless benefits expire by early spring, which would necessitate more funding.”

 

Charts We Found Interesting

 

1. The first Covid-19 shots have been given to more than 1.1 million people in four countries, according to data collected by Bloomberg. The chart below shows how the first round of vaccines are being distributed in the U.S.

 

 

2. The vaccines obviously can’t come soon enough.

 

 

3. The good news is that key countries have seen a meaningful improvement. Once again, Japan is simply on a different page than everyone else.

 

 

4. Science works at a different speed today.

 

 

5. There is a lot of talk about how super low interest rates will fuel inflation in 2021 or 2022. At least in Europe, they really haven’t seen inflation above 2% despite years of low (or negative) rates.

 

 

6. And of course, Japan is the deflationary poster child. Prices fell almost 1% this last month despite the Bank of Japan turning into the largest holder of Japanese equities in the world.

 

 

7. During recessions/bear markets investors build up a lot cash reserves. During the subsequent recovery this cash is reinvested. Cash holdings are still far from being back to normal.

 

 

8. So far it is a dry year in California. The reservoir situation is a mixed bag, but in general they aren’t in terrible shape yet.

 

 

Have a good weekend.

 

 

 

Published by Gemmer Asset Management LLC The material presented (including all charts, graphs and statistics) is based on current public information that we consider reliable, but we do not represent it is accurate or complete, and it should not be relied on as such. The material is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. It does not constitute a personal recommendation or take into account the particular investment objective, financial situations, or needs of individual clients. Clients should consider whether any advice or recommendation in this material is suitable for their particular circumstances and, if appropriate, see professional advice, including tax advice. The price and value of investments referred to in this material and the income from them may fluctuate. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. Fluctuations in exchange rates could have adverse effects on the value or prices of, or income derive from, certain investments. No part of this material may be (i) copied, photocopied or duplicated in any form by any means or (ii) redistributed without the prior written consent of Gemmer Asset Management LLC (GAM). Any mutual fund performance presented in this material are used to illustrate opportunities within a diversified portfolio and do not represent the only mutual funds used in actual client portfolios. Any allocation models or statistics in this material are subject to change. GAM may change the funds utilized and/or the percentage weightings due to various circumstances. Please contact GAM, your advisor or financial representative for current inflation on allocation, account minimums and fees. Any major market indexes that are presented are unmanaged indexes or index-based mutual funds commonly used to measure the performance of the US and global stock/bond markets. These indexes have not necessarily been selected to represent an appropriate benchmark for the investment or model portfolio performance, but rather is disclosed to allow for comparison to that of well known, widely recognized indexes. The volatility of all indexes may be materially different from that of client portfolios. This material is presented for informational purposes. We maintain a list of all recommendations made in our allocation models for at least the previous 12 months. If you would like a complete listing of previous and current recommendations, please contact our office.